中国伴年龄相关性调节不足屈光不正患者激光角膜屈光手术专家共识(2021年)

2021-09-11 中国医师协会眼科医师分会 中华眼科杂志. 2021,57(09)

伴年龄相关性调节不足的屈光不正人群,在接受激光角膜屈光手术后摘掉矫正屈光不正眼镜的同时,需要避免因出现老视症状而过早配戴"老花镜"。因此,该人群在激光角膜屈光手术围手术期需要进行更为严格的术前筛查,采

中文标题:

中国伴年龄相关性调节不足屈光不正患者激光角膜屈光手术专家共识(2021年)

发布日期:

2021-09-11

简要介绍:

伴年龄相关性调节不足的屈光不正人群,在接受激光角膜屈光手术后摘掉矫正屈光不正眼镜的同时,需要避免因出现老视症状而过早配戴"老花镜"。因此,该人群在激光角膜屈光手术围手术期需要进行更为严格的术前筛查,采用更为合理的个性化手术方案和术后护理模式,方能获得满意的手术疗效。为此,中国医师协会眼科医师分会屈光手术学组联合中华医学会眼科学分会相关专家,在总结临床经验的基础上,参考国内外相关研究结果,经过认真讨论和反复修改,形成本共识意见,旨在为临床规范开展激光角膜屈光手术矫正伴年龄相关性调节不足人群的屈光不正提供指导和参考。(中华眼科杂志,2021,57:651-657)
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国伴年龄相关性调节不足屈光不正患者激光角膜屈光手术专家共识(2021年).pdf)] GetToolGuiderByIdResponse(projectId=1, id=d09561c00219210e, title=中国伴年龄相关性调节不足屈光不正患者激光角膜屈光手术专家共识(2021年), enTitle=, guiderFrom=中华眼科杂志. 2021,57(09), authorId=0, author=, summary=伴年龄相关性调节不足的屈光不正人群,在接受激光角膜屈光手术后摘掉矫正屈光不正眼镜的同时,需要避免因出现老视症状而过早配戴"老花镜"。因此,该人群在激光角膜屈光手术围手术期需要进行更为严格的术前筛查,采, cover=https://img.medsci.cn/2021923/1632409954255_2020535.jpg, journalId=0, articlesId=null, associationId=1388, associationName=中国医师协会眼科医师分会, associationIntro=, copyright=0, guiderPublishedTime=Sat Sep 11 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">伴年龄相关性调节不足的屈光不正人群,在接受激光角膜屈光手术后摘掉矫正屈光不正眼镜的同时,需要避免因出现老视症状而过早配戴"老花镜"。因此,该人群在激光角膜屈光手术围手术期需要进行更为严格的术前筛查,采用更为合理的个性化手术方案和术后护理模式,方能获得满意的手术疗效。为此,中国医师协会眼科医师分会屈光手术学组联合中华医学会眼科学分会相关专家,在总结临床经验的基础上,参考国内外相关研究结果,经过认真讨论和反复修改,形成本共识意见,旨在为临床规范开展激光角膜屈光手术矫正伴年龄相关性调节不足人群的屈光不正提供指导和参考。(中华眼科杂志,2021,57:651-657)</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=35589, tagName=屈光不正)], categoryList=[CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=35589, guiderKeyword=屈光不正, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5039, appHits=107, showAppHits=0, pcHits=848, showPcHits=4932, likes=0, shares=12, comments=6, approvalStatus=1, publishedTime=Thu Sep 23 23:40:40 CST 2021, publishedTimeString=2021-09-11, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 23 23:12:54 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 12:22:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国伴年龄相关性调节不足屈光不正患者激光角膜屈光手术专家共识(2021年).pdf)])
中国伴年龄相关性调节不足屈光不正患者激光角膜屈光手术专家共识(2021年).pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1187949, encodeId=15e5118e949b9, content=很好,很实用,认真学习贯彻落实共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:02:07 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063317, encodeId=9c72106331e53, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=657e2469774, createdName=124355d0m30暂无昵称, createdTime=Sun Oct 24 00:29:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054345, encodeId=b234105434595, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4bbc2874608, createdName=xiexl, createdTime=Fri Sep 24 07:31:05 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054327, encodeId=9128105432ecd, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/0bf5f727d5fb4f3a8cf82a0c93693a76/cf97d155684f43509e1bfec0587b7d25.jpg, createdBy=291f5157511, createdName=大家好, createdTime=Fri Sep 24 03:38:18 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2022-01-25 ms9000001995137444

    很好,很实用,认真学习贯彻落实共识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1187949, encodeId=15e5118e949b9, content=很好,很实用,认真学习贯彻落实共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:02:07 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063317, encodeId=9c72106331e53, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=657e2469774, createdName=124355d0m30暂无昵称, createdTime=Sun Oct 24 00:29:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054345, encodeId=b234105434595, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4bbc2874608, createdName=xiexl, createdTime=Fri Sep 24 07:31:05 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054327, encodeId=9128105432ecd, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/0bf5f727d5fb4f3a8cf82a0c93693a76/cf97d155684f43509e1bfec0587b7d25.jpg, createdBy=291f5157511, createdName=大家好, createdTime=Fri Sep 24 03:38:18 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2021-10-24 124355d0m30暂无昵称

    很棒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1187949, encodeId=15e5118e949b9, content=很好,很实用,认真学习贯彻落实共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:02:07 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063317, encodeId=9c72106331e53, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=657e2469774, createdName=124355d0m30暂无昵称, createdTime=Sun Oct 24 00:29:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054345, encodeId=b234105434595, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4bbc2874608, createdName=xiexl, createdTime=Fri Sep 24 07:31:05 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054327, encodeId=9128105432ecd, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/0bf5f727d5fb4f3a8cf82a0c93693a76/cf97d155684f43509e1bfec0587b7d25.jpg, createdBy=291f5157511, createdName=大家好, createdTime=Fri Sep 24 03:38:18 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2021-09-24 xiexl

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1187949, encodeId=15e5118e949b9, content=很好,很实用,认真学习贯彻落实共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3fa6482137, createdName=ms9000001995137444, createdTime=Tue Jan 25 10:02:07 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063317, encodeId=9c72106331e53, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=657e2469774, createdName=124355d0m30暂无昵称, createdTime=Sun Oct 24 00:29:47 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054345, encodeId=b234105434595, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4bbc2874608, createdName=xiexl, createdTime=Fri Sep 24 07:31:05 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054327, encodeId=9128105432ecd, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/0bf5f727d5fb4f3a8cf82a0c93693a76/cf97d155684f43509e1bfec0587b7d25.jpg, createdBy=291f5157511, createdName=大家好, createdTime=Fri Sep 24 03:38:18 CST 2021, time=2021-09-24, status=1, ipAttribution=)]
    2021-09-24 大家好

    0

拓展阅读

WS/T 663—2020 中小学生屈光不正筛查规范

中华人民共和国国家卫生健康委员会 · 2020-05-31